TABLE 2

Bacterial strains used in this study

StrainCharacteristicsaSource or referenceb
PAO1Standard reference strain, isolated in 1954 (64)Martha Mulks
Tn::fabIISlacZ/hah38
AMT0023_30Early isolate, 6 mo65
AMT0023_34Late isolate, 8 yr65
CF_115_JP. aeruginosa clinical CF isolate, MichiganMartha Mulks
CF_110_NP. aeruginosa clinical CF isolate, MichiganMartha Mulks
CF_110_OP. aeruginosa clinical CF isolate, MichiganMartha Mulks
CF_131_MP. aeruginosa clinical CF isolate, MichiganMartha Mulks
CF_300_AP. aeruginosa clinical CF isolate, MichiganMartha Mulks
AU1054BCC clinical CF isolate, USAJ. J. LiPuma
PC184BCC clinical CF isolate, Cleveland OhioJ. J. LiPuma
AU2289BCC clinical CF isolate, MichiganJ. J. LiPuma
H12424Soil, onion field, New YorkJ. J. LiPuma
J2315BCC clinical CF isolate, Edinburgh, UKJ. J. LiPuma
USA_300_JE2MRSA, wound, California61
COLMRSA, Colindale Hospital, England61
Newman (25904)MSSA, wound, endocarditisNeal Hammer ATCC
Wichita (29213)MSSA, better biofilm formerATCC
  • a BCC, Burkholderia cenocepacia complex; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; ATCC, American Tissue Type Collection.

  • b J. J. LiPuma, U.S. Burkholderia cenocepacia Research Laboratory and Repository, UM, Ann Arbor, MI.